Individualised Versus Conventional Balloon Dilation for TIPS : Hepatic Encephalopathy in a Propensity‐Matched Before‐After Study
Liver International · 2026-12 · 46 (12)
DOI: 10.1111/liv.70992 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Liver International, online erschienen am 17.11.2026. Verfasst von Peng-Cheng Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xinqiao Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Hepatic Encephalopathy, Portasystemic Shunt, Transjugular Intrahepatic, Liver Cirrhosis, Dilatation. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background and Aims Hepatic encephalopathy (HE) is a major complication of transjugular intrahepatic portosystemic shunt (TIPS). Stent under‐dilation reduces HE, but a fixed diameter cannot be individualised to patient risk. An individualised scoring system tailoring balloon diameter to patient characteristics, without compromising efficacy or increasing variceal re‐bleeding or stent dysfunction, is needed.
Methods
In this retrospective study, 717 patients with cirrhosis underwent TIPS with 8‐mm covered stents between December 2015 and December 2023. Patients received conventional 8‐mm full dilation ( n = 408; before December 1, 2020) or individualised dilation ( n = 309; from December 1, 2020 onward), with the balloon diameter (5–7 mm) chosen by an 11‐factor scoring system. The primary endpoint was overt HE (West Haven grade II–IV) within 6 months. Propensity score matching, inverse probability weighting, Fine–Grey and E‐value analyses were performed.
Results
Six‐month overt HE was lower in the individualised group (14.6%; 45 of 309) than in the conventional group (27.5%; 112 of 408), yielding an absolute risk reduction of 12.9 percentage points (number needed to treat, 8; p < 0.001). After propensity score matching on 18 covariates (259 pairs), the conditional odds ratio was 0.42 (95% CI, 0.27–0.66; p < 0.001), consistent with inverse probability weighting (odds ratio, 0.47). Six‐month re‐bleeding (1.5% vs. 1.3%), stent dysfunction (3.9% vs. 4.2%) and ascites improvement (61.0% vs. 62.1%) did not differ significantly.
Conclusions
An individualised balloon dilation strategy incorporating an 11‐factor scoring system was associated with reduced post‐TIPS HE, with no clear difference in variceal re‐bleeding, stent dysfunction or ascites recurrence. Trial Registration Chinese Clinical Trial Registry, ChiCTR2400087533
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Xinqiao Hospital, Army Medical University, Chongqing, China.
- Independent Researcher, Dongguan, China.
- Dianjiang Traditional Chinese Medicine Hospital, Chongqing University of Chinese Medicine, Chongqing, China.
ORCID-Profile: Peng-Cheng Ji, Zheng-Guo Xu
Zitieren
APA
Ji, P. C., Huang, G. P., Huang, J. Y., Luo, W. J., Hu, S. J., Yang, Y., & Xu, Z. G. (2026). Individualised Versus Conventional Balloon Dilation for TIPS : Hepatic Encephalopathy in a Propensity‐Matched Before‐After Study. Liver International, 46(12). https://doi.org/10.1111/liv.70992
Vancouver
Ji PC, Huang GP, Huang JY, Luo WJ, Hu SJ, Yang Y, et al. Individualised Versus Conventional Balloon Dilation for TIPS : Hepatic Encephalopathy in a Propensity‐Matched Before‐After Study. Liver International. 2026;46(12). doi:10.1111/liv.70992
BibTeX
@article{Ji2026,
author = {Ji, Peng-Cheng and Huang, Gui-Ping and Huang, Jin-Yuan and Luo, Wen-Jun and Hu, Si-Jie and Yang, Yin and Xu, Zheng-Guo},
title = {Individualised Versus Conventional Balloon Dilation for TIPS : Hepatic Encephalopathy in a Propensity‐Matched Before‐After Study},
journal = {Liver International},
year = {2026},
volume = {46},
number = {12},
doi = {10.1111/liv.70992}
}
EUVIMED